BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2101674)

  • 1. The effect of tamoxifen on cervical squamous maturation in Papanicolaou stained cervical smears of post-menopausal women.
    Eells TP; Alpern HD; Grzywacz C; MacMillan RW; Olson JE
    Cytopathology; 1990; 1(5):263-8. PubMed ID: 2101674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of tamoxifen on cervicovaginal smears from patients with breast cancer.
    Abadi MA; Barakat RR; Saigo PE
    Acta Cytol; 2000; 44(2):141-6. PubMed ID: 10740597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small cells in cervical-vaginal smears of patients treated with tamoxifen.
    Opjorden SL; Caudill JL; Humphrey SK; Salomão DR
    Cancer; 2001 Feb; 93(1):23-8. PubMed ID: 11241262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of tamoxifen on the cytology of the uterine cervix in breast cancer patients.
    Gill BL; Simpson JF; Somlo G; McGonigle KF; Wilczynski SP
    Diagn Cytopathol; 1998 Dec; 19(6):417-22. PubMed ID: 9839130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytodiagnostic problems in cervicovaginal smears from symptomatic breast cancer patients on tamoxifen therapy.
    Ajit D; Gavas S; Jagtap S; Chinoy RF
    Acta Cytol; 2009; 53(4):383-8. PubMed ID: 19697721
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The small blue cell dilemma associated with tamoxifen therapy.
    Yang YJ; Trapkin LK; Demoski RK; Bellerdine J; Powers CN
    Arch Pathol Lab Med; 2001 Aug; 125(8):1047-50. PubMed ID: 11473455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of Ki-67 antigen staining in Papanicolaou (Pap) smears in post-menopausal women with atypia--an audit.
    Ejersbo D; Jensen HA; Hølund B
    Cytopathology; 1999 Dec; 10(6):369-74. PubMed ID: 10607007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paired Papanicolaou smears in the evaluation of atypical squamous cells.
    Andrews S; Hernandez E; Miyazawa K
    Obstet Gynecol; 1989 May; 73(5 Pt 1):747-50. PubMed ID: 2704501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maturation of vaginal and endometrial epithelium in postmenopausal breast cancer patients receiving long-term tamoxifen.
    Lahti E; Vuopala S; Kauppila A; Blanco G; Ruokonen A; Laatikainen T
    Gynecol Oncol; 1994 Dec; 55(3 Pt 1):410-4. PubMed ID: 7835781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The validity of Pap smear parameters as predictors of endometrial pathology in menopausal women.
    Zucker PK; Kasdon EJ; Feldstein ML
    Cancer; 1985 Nov; 56(9):2256-63. PubMed ID: 4052970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tamoxifen and proliferation of vaginal and cervical epithelium in postmenopausal women with breast cancer.
    Friedrich M; Mink D; Villena-Heinsen C; Woll-Hermann A; Schmidt W
    Eur J Obstet Gynecol Reprod Biol; 1998 Oct; 80(2):221-5. PubMed ID: 9846673
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytological evaluation of the effect of Tamoxifen in premenopausal and post-menopausal women with primary breast cancer by analysis of the karyopyknotic indices of vaginal smears.
    Athanassiadou PP; Kyrkou KA; Antoniades LG; Athanassiades PH
    Cytopathology; 1992; 3(4):203-8. PubMed ID: 1421004
    [TBL] [Abstract][Full Text] [Related]  

  • 13. False-negative results in cervical cytologic studies.
    Gay JD; Donaldson LD; Goellner JR
    Acta Cytol; 1985; 29(6):1043-6. PubMed ID: 3866457
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Value of histiocyte detection in Pap smears for predicting endometrial pathology. An institutional experience.
    Nassar A; Fleisher SR; Nasuti JF
    Acta Cytol; 2003; 47(5):762-7. PubMed ID: 14526675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence and evaluation of an AGUS Papanicolaou smear in primary care.
    Valdini A; Vaccaro C; Pechinsky G; Abernathy V
    J Am Board Fam Pract; 2001; 14(3):172-7. PubMed ID: 11355048
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenocarcinomas in the cervicovaginal Papanicolaou smear: analysis of a 12-year experience.
    Kim HS; Underwood D
    Diagn Cytopathol; 1991; 7(2):119-24. PubMed ID: 2065563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postmenopausal vaginal cytohormonal pattern in 597 healthy women and 301 patients with genital cancer.
    Efstratiades M; Tamvakopoulou E; Papatheodorou B; Batrinos M
    Acta Cytol; 1982; 26(2):126-30. PubMed ID: 6952711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gynaecological cytology and pelvic ultrasonography in patients with breast cancer taking tamoxifen compared with controls.
    Rayter Z; Gazet JC; Shepherd J; Trott PA; Fisher C; Svensson WE; Ford HT; A'Hern R
    Eur J Surg Oncol; 1994 Apr; 20(2):134-40. PubMed ID: 8181578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the atypical squamous cell Papanicolaou smear.
    Maier RC; Schultenover SJ
    Int J Gynecol Pathol; 1986; 5(3):242-8. PubMed ID: 3759323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of normal endometrial cells detected by cervical cytology.
    Cherkis RC; Patten SF; Andrews TJ; Dickinson JC; Patten FW
    Obstet Gynecol; 1988 Feb; 71(2):242-4. PubMed ID: 3336559
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.